Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Stocks Retirees Should Absolutely Love


Dividend stocks can practically be a retiree's best friend. At least, the right ones can be. Three Motley Fool contributors were asked to identify healthcare Dividend stocks they think retirees should absolutely love now. Here's why they picked (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).

Prosper Junior Bakiny (AbbVie): Retirees are usually attracted to steady dividend payers. AbbVie fits that description quite well. With 51 years of consecutive payout increases under its belt, the drugmaker has earned a place in the select group of companies known as the Dividend Kings. In the past decade alone, its management has raised its dividends by an impressive 270%.

The company has been able to sustain these increases thanks to its solid underlying business. AbbVie bears might point out that its key asset through this period was Humira, a blockbuster immunology medicine that has now lost patent exclusivity and sales of which are declining. The company expects its top line to sink this year and next as a result.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€175.30
0.030%
There is nearly no change for the AbbVie Inc. stock today. Compared to yesterday it only changed by €0.060.
With 34 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 180 € there is a slightly positive potential of 2.68% for AbbVie Inc. compared to the current price of 175.3 €.
Like: 0
PFE
Share

Comments